Abstract

Cross-reactive CD4+ T cells that recognize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more commonly detected in the peripheral blood of unexposed individuals compared with SARS-CoV-2–reactive CD8+ T cells. However, large numbers of memory CD8+ T cells reside in tissues, feasibly harboring localized SARS-CoV-2–specific immune responses. To test this idea, we performed a comprehensive functional and phenotypic analysis of virus-specific T cells in tonsils, a major lymphoid tissue site in the upper respiratory tract, and matched peripheral blood samples obtained from children and adults before the emergence of COVID-19 (coronavirus disease 2019). We found that SARS-CoV-2–specific memory CD4+ T cells could be found at similar frequencies in the tonsils and peripheral blood in unexposed individuals, whereas functional SARS-CoV-2–specific memory CD8+ T cells were almost only detectable in the tonsils. Tonsillar SARS-CoV-2–specific memory CD8+ T cells displayed a follicular homing and tissue-resident memory phenotype, similar to tonsillar Epstein-Barr virus–specific memory CD8+ T cells, but were functionally less potent than other virus-specific memory CD8+ T cell responses. The presence of preexisting tissue-resident memory CD8+ T cells in unexposed individuals could potentially enable rapid sentinel immune responses against SARS-CoV-2.

Highlights

  • COVID-19 has caused millions of deaths worldwide, and hundreds of millions of people have been infected with the causative agent, SARS-CoV-2 [1]

  • To optimize assays for the detection of virus-specific mCD4+ and mCD8+ T cell responses in the upper respiratory tract, we first compared the expression of activation-induced markers (AIMs) on the cell surface (PD-L1, CD25, CD134/OX40, and CD137/4-1BB) or the intracellular expression of AIMs (4-1BB and CD154/CD40L) and cytokines (TNFα and IFN-γ) in the absence or presence of virus peptide stimulation

  • Cells were stimulated with overlapping peptide pools spanning the spike, nucleocapsid, membrane, envelope, ORF1a, ORF1b, and ORF3–10 proteins of SARS-CoV-2 and selected immunodominant proteins encoded by Epstein-Barr virus (EBV), cytomegalovirus (CMV), or human coronaviruses (HCoVs)-OC43 (Fig. 1A, Fig. S3A)

Read more

Summary

Introduction

COVID-19 has caused millions of deaths worldwide, and hundreds of millions of people have been infected with the causative agent, SARS-CoV-2 [1]. Pre-existing immunity against SARS-CoV-2 may modulate the severity of COVID-19 [5]. Several studies have reported the existence of functional T cell responses in the peripheral blood of SARS-CoV-2unexposed individuals that cross-recognize SARS-CoV-2 [6,7,8,9,10,11,12,13,14]. CoV-2-specific mCD8+ T cells are much less common These pre-existing cellular immune responses are likely generated by previous infections with common cold human coronaviruses (HCoVs), which share considerable sequence homology with SARS-CoV-2 [12], other pathogens have been implicated in this phenomenon [15, 16]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call